Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Protocol DUR001-106: A Phase 1, Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 months to 11 years receiving Standard Intravenous...
Yogev, Ram
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
6/24/13
→
12/31/14
Funding
Duke University
Durata Therapeutics International B.V.
View all
View less